These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 20083470)

  • 1. Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes.
    Jaziri R; Aubert R; Roussel R; Emery N; Maimaitiming S; Bellili N; Miot A; Saulnier PJ; Travert F; Hadjadj S; Marre M; Fumeron F;
    Nephrol Dial Transplant; 2010 Jul; 25(7):2231-7. PubMed ID: 20083470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin in chronic heart failure: influence of diabetes and genetic variants.
    Masson S; Gori F; Latini R; Milani V; Flyvbjerg A; Frystyk J; Crociati L; Pietri S; Vago T; Barlera S; Maggioni AP; Tognoni G; Tavazzi L; Omland T; Franzosi MG;
    Eur J Clin Invest; 2011 Dec; 41(12):1330-8. PubMed ID: 21623778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Nucleotide Polymorphisms in exon 3 of the adiponectin gene in subjects with type 2 diabetes mellitus.
    Kretowski A; Gugała K; Okruszko A; Wawrusiewicz-Kurylonek N; Górska M
    Rocz Akad Med Bialymst; 2005; 50():148-50. PubMed ID: 16358955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women.
    Jang Y; Chae JS; Koh SJ; Hyun YJ; Kim JY; Jeong YJ; Park S; Ahn CM; Lee JH
    Clin Chim Acta; 2008 May; 391(1-2):85-90. PubMed ID: 18328815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter.
    Schwarz PE; Towers GW; Fischer S; Govindarajalu S; Schulze J; Bornstein SR; Hanefeld M; Vasseur F
    Diabetes Care; 2006 Jul; 29(7):1645-50. PubMed ID: 16801592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
    Zhang D; Ma J; Brismar K; Efendic S; Gu HF
    J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter adiponectin polymorphisms and waist/hip ratio variation in a prospective French adults study.
    Dolley G; Bertrais S; Frochot V; Bebel JF; Guerre-Millo M; Tores F; Rousseau F; Hager J; Basdevant A; Hercberg S; Galan P; Oppert JM; Lacorte JM; Clément K
    Int J Obes (Lond); 2008 Apr; 32(4):669-75. PubMed ID: 18071343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies: response to Hadjadj et al.
    Ng DP
    Diabetes Care; 2008 Oct; 31(10):e78; author reply e79. PubMed ID: 18820224
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.
    Hadjadj S; Fumeron F; Roussel R; Saulnier PJ; Gallois Y; Ankotche A; Travert F; Abi Khalil C; Miot A; Alhenc-Gelas F; Lievre M; Marre M; ; ;
    Diabetes Care; 2008 Sep; 31(9):1847-52. PubMed ID: 18523145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women.
    Pischon T; Pai JK; Manson JE; Hu FB; Rexrode KM; Hunter D; Rimm EB
    Obesity (Silver Spring); 2007 Aug; 15(8):2051-60. PubMed ID: 17712123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recessive protective effect of ADIPOQ rs1501299 on cardiovascular diseases with type 2 diabetes: a meta-analysis.
    Sun K; Li Y; Wei C; Tong Y; Zheng H; Guo Y
    Mol Cell Endocrinol; 2012 Feb; 349(2):162-9. PubMed ID: 22040602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population.
    Chiodini BD; Specchia C; Gori F; Barlera S; D'Orazio A; Pietri S; Crociati L; Nicolucci A; Franciosi M; Signorini S; Brambilla P; Grazia Franzosi M; ;
    Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):223-30. PubMed ID: 20576642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population.
    Lee YY; Lee NS; Cho YM; Moon MK; Jung HS; Park YJ; Park HJ; Youn BS; Lee HK; Park KS; Shin HD
    Diabet Med; 2005 May; 22(5):569-75. PubMed ID: 15842511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
    Wang Y; Ng MC; So WY; Ma R; Ko GT; Tong PC; Chan JC
    Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.
    Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes.
    Al-Daghri NM; Al-Attas OS; Alokail MS; Alkharfy KM; Hussain T
    Mol Biol Rep; 2011 Aug; 38(6):3703-8. PubMed ID: 21400095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.